Antitumor effect of temsirolimus against oral squamous cell carcinoma associated with bone destruction

Tatsuo Okui; Tsuyoshi Shimo; Takuya Fukazawa; Naito Kurio; Nur Hassan; Tatsuki Honami; Munenori Takaoka; Yoshio Naomoto; Akira Sasaki

Antitumor effect of temsirolimus against oral squamous cell carcinoma associated with bone destruction

Tatsuo Okui, Tsuyoshi Shimo, Takuya Fukazawa, Naito Kurio, Nur Hassan, Tatsuki Honami, Munenori Takaoka, Yoshio Naomoto, Akira Sasaki

Research output: Contribution to journal › Article › peer-review

31 Citations (Scopus)

Original language	English
Pages (from-to)	2960-2969
Number of pages	10
Journal	Molecular Cancer Therapeutics
Volume	9
Issue number	11
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{327f075b51de4359b37c1ce6ad030d97,

title = "Antitumor effect of temsirolimus against oral squamous cell carcinoma associated with bone destruction",

author = "Tatsuo Okui and Tsuyoshi Shimo and Takuya Fukazawa and Naito Kurio and Nur Hassan and Tatsuki Honami and Munenori Takaoka and Yoshio Naomoto and Akira Sasaki",

note = "Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = Molecular cancer therapeutics. ISSNs: 1538-8514; ",

year = "2010",

language = "English",

volume = "9",

pages = "2960--2969",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "11",

}

TY - JOUR

T1 - Antitumor effect of temsirolimus against oral squamous cell carcinoma associated with bone destruction

AU - Okui, Tatsuo

AU - Shimo, Tsuyoshi

AU - Fukazawa, Takuya

AU - Kurio, Naito

AU - Hassan, Nur

AU - Honami, Tatsuki

AU - Takaoka, Munenori

AU - Naomoto, Yoshio

AU - Sasaki, Akira

N1 - Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = Molecular cancer therapeutics. ISSNs: 1538-8514;

PY - 2010

Y1 - 2010

M3 - Article

SN - 1535-7163

VL - 9

SP - 2960

EP - 2969

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

IS - 11

ER -